IRIS
DI MARCO, Roberto Maria Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.230
AS - Asia 3.308
EU - Europa 1.699
SA - Sud America 668
AF - Africa 257
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.075
CN - Cina 1.261
SG - Singapore 1.207
BR - Brasile 592
IT - Italia 568
IE - Irlanda 353
KR - Corea 333
UA - Ucraina 280
HK - Hong Kong 217
CI - Costa d'Avorio 178
CA - Canada 123
VN - Vietnam 107
DE - Germania 106
RU - Federazione Russa 94
SE - Svezia 72
GB - Regno Unito 52
IN - India 40
SN - Senegal 36
AR - Argentina 27
AT - Austria 27
FI - Finlandia 25
FR - Francia 23
BD - Bangladesh 21
PL - Polonia 21
MX - Messico 20
TR - Turchia 20
NL - Olanda 19
ZA - Sudafrica 18
EC - Ecuador 17
ID - Indonesia 15
UZ - Uzbekistan 13
CH - Svizzera 12
BG - Bulgaria 11
IQ - Iraq 11
PK - Pakistan 11
IR - Iran 10
AU - Australia 8
GR - Grecia 8
JP - Giappone 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 6
CO - Colombia 6
MA - Marocco 6
PE - Perù 6
AZ - Azerbaigian 5
BE - Belgio 5
CL - Cile 5
DO - Repubblica Dominicana 5
TN - Tunisia 5
CZ - Repubblica Ceca 4
LB - Libano 4
MK - Macedonia 4
PY - Paraguay 4
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
RO - Romania 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
ES - Italia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
NG - Nigeria 2
PH - Filippine 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BW - Botswana 1
CR - Costa Rica 1
CV - Capo Verde 1
DM - Dominica 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KI - Kiribati 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 12.175
Salva come PNG Salva come JPEG
Città #
Dallas 2.434
Santa Clara 879
Singapore 687
Hefei 650
Jacksonville 365
Dublin 353
Seoul 331
Chandler 263
Houston 211
Abidjan 178
Civitanova Marche 160
Catania 155
Boardman 154
Chicago 135
Nanjing 99
Cambridge 95
Andover 94
Lawrence 94
Ashburn 90
Toronto 87
Beijing 84
Los Angeles 58
Des Moines 45
San Mateo 45
São Paulo 45
Wilmington 43
Ho Chi Minh City 40
Grafing 37
Dakar 36
Hebei 32
Nanchang 28
Rio de Janeiro 24
Brooklyn 23
Campobasso 20
Ottawa 20
Jiaxing 19
Hanoi 18
Saint Petersburg 17
Tianjin 17
Nuremberg 16
Rome 16
Shenyang 16
Changsha 14
Columbus 14
New York 14
San Francisco 14
The Dalles 14
Lappeenranta 13
Munich 13
Naples 13
Bremen 12
Palermo 12
Phoenix 12
Belo Horizonte 11
Brasília 11
London 11
Moscow 11
Vienna 11
Warsaw 11
Curitiba 10
Dong Ket 10
Hangzhou 10
Maletto 9
Porto Alegre 9
Salerno 9
Salvador 9
Seattle 9
Turku 9
Atlanta 8
Hong Kong 8
Juiz de Fora 8
Milan 8
Tokyo 8
Augusta 7
Istanbul 7
Johannesburg 7
Leawood 7
Montreal 7
Mountain View 7
Mumbai 7
Stockholm 7
Tashkent 7
Cape Town 6
Caxias do Sul 6
Guarulhos 6
Manchester 6
Norwalk 6
Washington 6
Amsterdam 5
Ardabil 5
Baghdad 5
Baku 5
Brussels 5
Chennai 5
Frankfurt Am Main 5
Guayaquil 5
Kunming 5
Padova 5
Paris 5
Ribeirão Preto 5
Totale 8.707
Salva come PNG Salva come JPEG
Nome #
Microbial gatekeepers: midgut bacteria in Aedes mosquitoes as modulators of arboviral transmission and targets for sustainable vector control 397
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 362
N-acetylcysteine causes analgesia by activating group II metabotropic glutamate receptors 298
Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. 263
Immunesystem to Brain Signaling and Vice Versa: The Role of Tryptophan and Glutamate 166
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 160
Beneficial effect of mGlu4 receptor activation on multiple animal models of autoimmune disease 159
Rifamycin SV: evaluation of the activity in DNB-induced colitis in rats and on IFNγ production in ConA-stimulated rat splenocytes 156
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 138
COMPOSIZIONE PER PREVENIRE O TRATTARE LA SINDROME DELL'OVAIO POLICISTICO E LA SINTOMATOLOGIA CORRELATA 125
Composition for the prevention or treatment of polycystic ovary syndrome and its related sumptoms 117
PARETE CELLULARE BATTERICA LEGATA A MUCOPOLISACCARIDE SUOI UTILIZZI E PROCESSO PER LA SUA PRODUZIONE 117
BACTERIAL STRAIN AND MEDICAL USES THEREOF 114
METODO PER RILEVARE LA PRESENZA E LA QUANTITA DEL RECETTORE LRP8 E DEI SUOI FRAMMENTI PROTEOLITICI, KIT DI RILEVAMENTO E RELATIVI ANTICORPI 112
ceppo batterico e suoi usi medici 112
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 110
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 107
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 105
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 104
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 103
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease 102
Increased rate of survial in streptococcus pneumoniae -infected rats treated with the new immunomodulator pitotimod 101
Expression of the oas gene family is highly modulated in subjects affected by juvenile dermatomyositis, resembling an immune response to a dsRNA virus infection 95
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: FC construct 93
Validità dell’autotrapianto di milza nella difesa dalle infezioni batteriche. Ricerche sperimentali 90
Microbiological and clinical periodontal effects of fixed orthodontic appliances in pediatric patients 81
Immunomodulatory properties of cefaclor: In vivo effect on cytokines release and lymphoprolipherative response on rat 80
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 78
Probiotics:overview of microbiological and immunological characteristics 78
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery 78
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 77
Preliminary in vitro studies on Corynebacterium urealyticum pathogenetic mechanisms, a possible candidate for chronic idiopathic prostatitis? 77
A Potential "Vitaminic Strategy" against Caries and Halitosis 75
DATI PRELIMINARI SULLE MODIFICAZIONI DI ALCUNI PARAMETRI DEL SISTEMA IMMUNITARIO UMANO INDOTTE DAL TRATTAMENTO CON CEFACLOR 74
Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures 74
FK-506 prevents diabetes in diabetes-prone BB/Wor rats 73
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 73
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 72
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 72
Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution 72
Dati preliminari sulle modificazioni di alcuni parametri del sistema immunitario umano indotte dal trattamento con cefaclor 70
The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse 69
Bactericidal activity and postantibiotic effect of cefdnir (ci 983, fk 482) against selected athogens 69
In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse 68
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 68
Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14 68
Human breast milk isolated lactic acid bacteria: antimicrobial and immunomodulatory activity on the Galleria mellonella burn wound model 67
Sodium fusidate in Guillain-Barre syndrome: a case report 67
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis 67
Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor properties 67
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 67
Expression of DNA methylation genes in secondary progressive multiple sclerosis 66
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 66
Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? 66
Protection from concanavalin A (Con A) induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate 65
Therapeutic effects of single administration of Cyclophosphamide in rat experimental autoimmune neuritis, a pre-clinical model of autoimmune peripheral neuropathies 65
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 65
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 65
Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock 65
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 63
Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody 63
Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-y 63
Protection from Experimental Autoimmune Thyroiditis in CBA Mice with the Novel Immunosuppressant Deoxyspergualin 63
Bactericidal kinetics and postantibiotic effect of Ciprofloxacin against B. catarrhalis, H. influenzae and S. pneumoniae 62
THE EFFECT OF CEFEPIME ON SOME IMMUNE PARAMETERS IN-VITRO - LACK OF INTERFERENCE WITH MITOGEN-INDUCED LYMPHOPROLIFERATION, IMMUNOGLOBULIN-SYNTHESIS, IFN-GAMMA AND IL-2 SECRETION AND IL-2 RECEPTOR EXPRESSION 62
The Effects of Deoxyspergualin on the Development of Diabetes in Diabetes‐Prone BB Rats 61
Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency 60
Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis 60
Glycopeptide- and carbohydrate-based synthetic vaccines for cancer immunotherapy 60
The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse 60
Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies 59
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism 59
Blood and bile levels of pefloxacin during biliary surgery 58
Increased serum levels of interleukin-18 in patients with multiple sclerosis 57
Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin 57
Epidemiology of antibiotic resistance in human isolates of Enterobacteriaceae in Sicily 56
Blood levels of transforming growth factor-beta 1 (TGF-beta 1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta 1b) 56
The new invasive mosquito species Aedes koreicus as vector-borne diseases in the European area, a focus on Italian region: What we know from the scientific literature 55
Akkermansia muciniphila: new insights into resistance to gastrointestinal stress, adhesion, and protein interaction with human mucins through optimised in vitro trials and bioinformatics tools 55
SUSCEPTIBILITY OF CLINICAL ISOLATES OF ENTEROBACTERIACEAE TO CEFDINIR (CI 983, FK 482) 55
Synergistic effect of deoxyspergualin (DSP) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats 55
Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat 55
Emerging Evidence on Tenebrio molitor Immunity: A Focus on Gene Expression Involved in Microbial Infection for Host-Pathogen Interaction Studies 54
Activation of mGlu4 metabotropic glutamate receptors inhibits the development of experimental autoimmune encephalomyelitis in mice. Soc. Neurosci 54
Increased rate of survival in streptococcus pneumoniae-infected rats treated with the new immunomodulator pidotimod 54
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 54
Investigation of Healthcare-Acquired Infections and Antimicrobial Resistance in an Italian Hematology Department before and during the COVID-19 Pandemic 53
Short-term treatment of relapsing remitting Multiple sclerosis patients with interferon (INF)-beta 1B transiently increases the blood levels of Interleukine (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta IL-2, IL-4 and Tumor necrosis factors-alfa 53
Efficacy and Microbiota Modulation Induced by LimpiAL 2.5%, a New Medical Device for the Inverse Psoriasis Treatment 52
Corrigendum to "Expression of DNA methylation genes in secondary progressive multiple sclerosis" [J. Neuroimmunol. 290 (2016) 66-9] 52
Correlation of the persistance or eradication of Porphyromonas gingivalis with pochet depth reduction in the treatment of periodontal Disease 52
Synergistic effect of deoxyspergualin (DPS) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats 52
In Vitro and In Vivo Biological Activity of Berberine Chloride against Uropathogenic E. coli Strains Using Galleria mellonella as a Host Model 52
Retrospective Investigator-Initiated Trial on Tocopherol Acetate Vaginal Administration in Pre-and Postmenopausal Women 52
Agenesis of gallbladder with choledocholithiasis: A case report 51
Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor 51
Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats 51
Innovative Phospholipid Carriers: A Viable Strategy to Counteract Antimicrobial Resistance 51
ROLE OF METABOTROPIC GLUTAMATE RECEPTOR IN EXPERIMENTAL MODEL OF MULTIPLE SCLEROSIS 50
The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta 1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells 50
Totale 8.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021459 0 0 0 4 141 13 73 2 73 2 119 32
2021/2022664 82 96 3 13 104 9 99 13 64 0 21 160
2022/20231.208 96 29 13 75 86 181 5 371 274 14 45 19
2023/2024438 19 62 18 40 16 100 5 35 2 17 79 45
2024/20253.870 7 275 116 471 894 295 200 144 318 364 311 475
2025/20264.568 623 1.303 2.549 93 0 0 0 0 0 0 0 0
Totale 12.520